# Breezebio

**Canonical:** https://apis.io/providers/breezebio/  
**Website:** https://breezebio.com/  
**APIs profiled:** 0

BreezeBio (formerly GenEdit) is a South San Francisco genetic-medicine company developing precision-delivered nucleic acid therapies for autoimmune disease and oncology. Its proprietary NanoGalaxy platform uses non-lipid, hydrophilic polymer nanoparticles of tunable size, charge, and composition to selectively deliver DNA, RNA, and ribonucleoprotein payloads to specific tissues and cell types beyond the liver — including immune cells and targets in the heart, lung, and central nervous system. The company is advancing an internal therapeutic pipeline led by BRZ-101, which aims to restore immune tolerance in type 1 diabetes, and in February 2026 closed a $60M Series B backed by DCVC Bio, Sequoia Capital, and other investors. BreezeBio is a research-stage biopharmaceutical company and does not currently publish a public developer API, SDKs, or API documentation; this profile tracks its corporate and identity surface within the API Evangelist network.

## Kin Score — 9.3 / 100 (minimal)

Scored 2026-08-20 under rubric 0.12.0. Trend: flat (+0.0 from 9.3).

| Facet | Score |
|---|---|
| Discoverability | 50.0 |
| Contract Quality | 0.0 |
| Governance | 0.0 |
| Contract Governance | 0.0 |
| Operational Transparency | 0.0 |
| Developer Ergonomics | 7.1 |
| Commercial Clarity | 21.1 |
| Access Clarity | 21.1 |

Regulatory layer — **Health**: 10.0 (matched via tags).

## Agent readiness — 0.0 (human-only)

| Dimension | Value |
|---|---|
| Spec Presence | no |
| Agentic Access | no |
| Reversibility Documented | no |
| MCP Server | no |
| Auth Clarity | no |
| Idempotency | no |
| Error Semantics | no |
| OpenAPI Examples | no |
| Rate Limit Signal | no |
| Event Surface Described | no |
| Agent Skills | no |
| Well Known Catalog | no |
| Consent Identity | no |
| Agent Card | no |
| Dry Run Mode | no |

## Access

Unknown — onboarding: unknown, pricing: unknown, trial: no (confidence: low).

## Tags

Company, Biotechnology, Genetic Medicine, Drug Delivery, Therapeutics, Life Sciences, Nanoparticles, Healthcare

---

Profiled by [API Evangelist](https://apievangelist.com) and published on [APIs.io](https://apis.io/providers/breezebio/). Scores are computed from the provider's own public artifacts under a published rubric.